InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,700.00
(
-0.02%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
78.70
(
0.00%
)
Bitcoin
63,096.32
(
1.03%
)
Post# of 253348
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

pharmaclown35

Send PM Follow Ignore
Followers 1
Posts 202
Boards Moderated 0
Alias Born 01/23/2008

pharmaclown35

Re: DewDiligence post# 130880

Monday, 11/28/2011 9:28:41 PM

Monday, November 28, 2011 9:28:41 PM

Post# of 253348
Yup. I agree. Who would have thought BG-12 stood a chance. But do you think the once-daily vs BID for BG-12 will make some MS patients less compliant in the real-world setting?

Also, ACOR -- - what / where can the company go from here. That's what I want to see. I keep waiting for them to in-lisence something good to add to their pipeline.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up